ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS
Anti-VEGF therapy has become the first-line treatment since the approval of anti-VEGF drugs for diabetic macular edema. These findings reflect the evolution of diabetic macular edema treatment and highlight the superiority of anti-VEGF therapy and its increased uptake over time.
Authors
- Noriaki Washio (ORCID: https://orcid.org/0000-0001-6627-7553)
- Masahiko Shimura (ORCID: https://orcid.org/0000-0001-5456-6374)
- Masahiko Sugimoto (ORCID: https://orcid.org/0000-0001-5147-4183)
- Kaori Yamamoto (ORCID: https://orcid.org/0000-0001-8113-629X)
- Taiichi Hikichi (ORCID: https://orcid.org/0000-0001-5572-8849)
- Takashi Koto (ORCID: https://orcid.org/0000-0003-4823-4386)
- Kunihiko Akiyama
- Tomoaki Tatsumi (ORCID: https://orcid.org/0000-0001-8271-9403)
- Hiroshi Enaida (ORCID: https://orcid.org/0000-0001-7808-3182)
- Teruyo Kida (ORCID: https://orcid.org/0000-0003-3074-162X)
- Yoshihiro Takamura (ORCID: https://orcid.org/0000-0003-0418-6829)
- Fumiki Okamoto (ORCID: https://orcid.org/0000-0001-6164-7164)
- Sentaro Kusuhara (ORCID: https://orcid.org/0000-0002-6458-539X)
- Fumi Gomi (ORCID: https://orcid.org/0000-0003-0807-8817)
- Yoko Takatsuna (ORCID: https://orcid.org/0000-0002-1209-0934)
- Tomoko Ueda‐Consolvo
- Tsuyoshi Iwase
- Hiroyuki Nakashizuka
- Jiro Kogo (ORCID: https://orcid.org/0000-0003-1259-1509)
- Kei Shinoda (ORCID: https://orcid.org/0000-0002-1543-9345)
- Takao Hirano (ORCID: https://orcid.org/0000-0003-3601-8053)
- Yoshihito Sakanishi (ORCID: https://orcid.org/0000-0002-2863-0165)
- Kazuhiro Kimura (ORCID: https://orcid.org/0000-0002-2502-6149)
- Mariko Sasaki (ORCID: https://orcid.org/0000-0001-5608-0546)
- Kosuke Nishi (ORCID: https://orcid.org/0000-0003-4205-8465)
- Taiji Nagaoka (ORCID: https://orcid.org/0000-0003-3933-1002)
- Rie Osaka (ORCID: https://orcid.org/0000-0002-8433-7473)
- Taiji Sakamoto (ORCID: https://orcid.org/0000-0003-0287-3801)
- Eiko Tsuiki
- Yoshinori Mitamura (ORCID: https://orcid.org/0000-0002-4813-672X)
- Shigeo Yoshida (ORCID: https://orcid.org/0000-0003-1049-8909)
- Shunichiro Ueda
- Toshinori Murata (ORCID: https://orcid.org/0000-0001-6577-5032)
- Takamasa Kinoshita (ORCID: https://orcid.org/0000-0002-0465-2140)
- Hiroto Terasaki (ORCID: https://orcid.org/0000-0003-4085-138X)
- Yuki Morizane (ORCID: https://orcid.org/0000-0002-7268-2640)
- T. Ueda
- Shinichi Sakamoto (ORCID: https://orcid.org/0000-0003-4671-0342)
- Shigehiko Kitano
- Akira Minamoto
Institutions
- Nihon University (JP)
- Kurume University (JP)
- Kagoshima University (JP)
- University of Fukui (JP)
- Hiroshima University (JP)
- Fukui University of Technology (JP)
- Center for Science in the Public Interest (United States) (US)
- Hyogo Medical University (JP)
- Shinshu University (JP)
- University of Tsukuba (JP)
- Jichi Medical University (JP)
- Tokyo Medical University (JP)
- Chiba University (JP)
- Okayama University (JP)
- St. Marianna University School of Medicine (JP)
- Yamaguchi University (JP)
- Saga University (JP)
- Mie University (JP)
- Wakayama Medical University (JP)
- Kyorin University (JP)
- Kagawa University (JP)
- Akita University (JP)
- Keio University (JP)
- Tokyo Medical University Hachioji Medical Center (JP)
- Tokyo Medical Center (JP)
- Showa General Hospital (JP)
- University of Fukui Hospital (JP)
- Ohtsuka Eye Hospital (JP)
- Tokyo Medical University Ibaraki Medical Center (JP)
- Tokyo Women's Medical University (JP)
- Juntendo University Urayasu Hospital (JP)
- Minamiaoyama Eye Clinic (JP)
- Tachikawa Hospital (JP)
- Sapporo City General Hospital (JP)
- Chiba Rosai Hospital (JP)
- Nihon University Itabashi Hospital (JP)
- University of Toyama (JP)
- Nagasaki University (JP)
- Nara Medical University (JP)
- Kobe University (JP)
- Hyogo University (JP)
- Saitama Medical University (JP)
- Osaka University of Pharmaceutical Sciences (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Retina
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1097/iae.0000000000004301
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.08
Funders
- Japan Society for the Promotion of Science